Philippine Society of ECMO, Inc.

Thank you Dr Bartlett 🙏

◾️In Memoriam of Robert Hawes Bartlett, MD 1939 - 2025 ◾️
Without Dr. Bartlett, there is no ECMO: Dr. Bartlett saved more than 100,000 patient lives globally through his life’s work on ECMO. He changed the world.
Known globally as the Father of ECMO, Robert H. Bartlett spent his life not only caring for the critically ill, but pioneering, establishing and teaching others new ways to provide life-saving support to these patients. ECMO, perhaps his most prestigious achievement, is today a standard of care for lung and/or cardiac support for premature infants to the elderly.
Dr. Bartlett was recruited to the University of Michigan in 1980. Bringing along his ECMO team, he established the ECLS laboratory, which is still active today, supports up to 100 students, residents, and investigators annually. In the early days at the University of Michigan, he created the ECMO program, which was largely focused on neonatal patients, but he advocated for an ECMO program that would address the needs of all patients.
With the success of ECMO, in 1989 he founded the ELSO - Extracorporeal Life Support Organization a global organization to inspire camaraderie while advancing technology, knowledge, and access. His charter message was that ELSO will be the “motor for research, the forum for discussion, the internal conscience, and the external voice of extracorporeal life support. Membership is exclusively limited to individuals with experience in extracorporeal life support and commitment to improving the state-of-the-art and science, but expansively inclusive to everyone with those characteristics.
He will forever be the Father of ECMO. He changed the landscape of surgery and critical care; he had friends all over the world and lived life fully. His work will continue to save lives. He will be missed by many and remembered by us all as an inspiration, a compassionate clinician, and a great intellect.

Vale, Dr Robert H Bartlett.
🔗 elso.org/ecmo-resources/drbartlett.aspx
🎥 Gibbons challenge fulfilled: award to Dr Bartlett
🔗 youtube.com/watch?v=4sfPgPIQ49s

https://zurl.co/YIRaH The YELENNA multinational prospective cohort (13 countries) enrolled 715 cancer patients with ARDS. Ninety-day mortality was 73%, and 82% in those with severe ARDS. ECMO use in severe ARDS showed no survival benefit after double-adjusted analyses. Independent mortality predictors included older age, peripheral vascular disease, severe ARDS, acute kidney injury and ICU-trial admission; lymphoma was associated with lower risk.

Prolonged mechanical ventilation pre VV in adults with
🗺️ national estimate of >9K patients
🪦 duration of pre-ECMO MV does not predict mortality in this population: prolonged MV alone may not necessarily preclude favorable outcomes
⏱️ late initiation of VV ECMO with MV > 7 days not associated with increased in-hospital mortality
Individualized approach to ECMO candidacy, rather
than reliance on rigid threshold, advisable.
Critical Care Medicine
🔗 http://bit.ly/461Q5Ct

for adult patients with
⚙️ technical aspects
📚 evidence for VV efficacy in very severe ARDS
📚 evidence for in ARDS
🫁 indications and timing of VV ECMO
🩺 clinical management of patients with VV: MV, prone positioning, hematologic management & blood transfusions, RV injury
🚦special considerations: awake ECMO, obesity, pregnancy, immunocompromised states, malignant disease
🏥 centre volume, logistics, hospital networks
🗺️ ECMO during respiratory pandemics
🔗 liberation from ECMO and outcomes
🔮 future research
Free to read on Intensive Care Medicine
🔓 https://rdcu.be/ezDWp

Congratulations and Thank you Dr Rod Castro for representing the Philippines in the Asia Pacific ELSO 2025 in Beijing, China.

Join us in APELSO 2025

📢 Join the 7th Asia-Pacific Extracorporeal Life Support Organization conference, co-sponsored by the Chinese Society of Biomedical Engineering & the APELSO Chapter of the ELSO - Extracorporeal Life Support Organization! We will reconvene in Beijing, where , first APELSO meeting was held in 2013, bringing together:
📌 leading experts, researchers, clinicians, industry professionals from across the Asia-Pacific region & more
📌 new & old friends to witness development of technology in China
📌 a platform for networking, collaboration, knowledge sharing to foster the critical environment of learning and exchange
📌 engaging ses­sions, including keynote speeches, panel discussions, exhibition sessions
📍 Beijing Landmark Towers Hotel, China 🇨🇳
🗓️ July 10-12 2025

🔗 https://apelso2025.sciconf.cn/

The National Kidney and Transplant Institute Nursing Department, in cooperation with PSECMO, held its 1st ECMO Training for Nurses: Critical Care Nursing - Competencies in ECMO last March 28, 2025.

NKTI, a pioneer in Nursing Care for ECMO, emphasizes the vital role our nurses play in ensuring the success of every ECMO run. Mabuhay ang mga Nurses!🇵🇭

Here’s to more ECMO education and training! Let’s save more lives! 💙❤️🫁

Happening now! Critical Care Nursing: Competencies in ECMO🫁❤️

It is with great pride and honor that Philippines is recognized as an Asia-Pacific Extracorpeal Life Support Organization (APELSO) member country
🎉🎉🎉

Thank you to the leadership of Dr Joselito Chavez. His unwavering efforts and enthusiasm to make this history happen is indeed contagious.

To the future of ECMO in the Philippines!! 🥂

Its a wrap!!
PCCP and PSECMO Post Graduate Course
ECMO in Pulmonary Critical Care

To those who were able to register
See you tom!!
P.S. Registration is closed.

Something’s brewing!🫁💠